0.1218NOK+4.10%Mkt Cap: 306.65M NOKP/E: —Last update: 2026-05-13
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. The company develops SoftOx…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B12.00
P/S19.68
EV/EBITDA-32.65
EV/Revenue17.14
EPS (TTM)0.00
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-6.16%
FCF Margin-121.16%
Operating CF-18.87M NOK
CapEx (TTM)—
Net Debt/EBITDA2.42
Net Debt-19.79M NOK
Technical
SMA 500.0988 (+23.3%)
SMA 2000.0828 (+47.0%)
Beta0.98
S&P 52W Chg24.23%
Avg Vol (30d)71.96M
Avg Vol (10d)20.50M
Technical Indicators
RSI (14)59.1
MACD0.0034
MACD Signal0.0038
MACD Hist.-0.0004
BB Upper0.1275 NOK
BB Middle0.1108 NOK
BB Lower0.0942 NOK
BB Width30.07%
ATR (14)0.0134 NOK
Vol Ratio (20d)1.04x
52W Range
0.049058% of range0.1745
52W High0.1745 NOK
52W Low0.0490 NOK
Profitability
Gross Margin100.00%
EBITDA Margin-52.49%
Profit Margin-69.39%
Oper. Margin-107.09%
ROE-47.11%
ROA-31.87%
Revenue Growth123.20%
Earnings Growth—
Balance Sheet
Debt/Equity0.00
Current Ratio1.80
Quick Ratio1.80
Book Value/Sh0.0100 NOK
Cash/Share0.0080 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split50:1
Split DateJul 2, 2018
Ownership
Shares Out.2.56B
Float1.04B
Insiders55.76%
Institutions3.13%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap306.65M NOK
Enterprise Value267.06M NOK
Revenue (TTM)15.58M NOK
Gross Profit15.58M NOK
Net Income (TTM)-10.81M NOK
Revenue/Share0.0070 NOK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
Last Price0.1218 NOK
CountryNO
SectorHealthcare
IndustryBiotechnology
ISIN—